GlaxoSmithKline ( ($GSK) ) has released its Q2 earnings. Here is a breakdown of the information GlaxoSmithKline presented to its investors.

China's Jiangsu Hengrui Pharmaceuticals said on Monday it has agreed to license the global rights of its HRS-9821 drug and 11 ...

British pharmaceutical group GlaxoSmithKline said Wednesday that its annual performance should be better than expected, ...

The Cambridge site of an international biotechnology company will cease manufacturing, leaving 150 people without a job.

Review the current GlaxoSmithKline Pharmaceuticals Ltd (GLAXO:XNSE) dividend yield and history to decide if GLAXO is the best investment for you.

With the stock's last traded price at Rs 3,081, GlaxoSmithKline Pharmaceuticals has experienced a notable decline, positioning it among the top losers on the Nifty Midcap 150 index.

Sydnie Mason laughs with her lab partner at the SNC GlaxoSmithKline Summer Immersion Experience in Biotech, a biotechnology ...

GlaxoSmithKline rejects Unilever's $68B consumer health buyout offer, but a bigger bid is brewing By Angus Liu Jan 18, 2022 7:55am analysts Consumer health M&A mergers and acquisitions ...

A global biopharmaceutical company headquartered in London announced the layoffs of 150 Massachusetts employees last week.

GlaxoSmithKline (GSK-0.81%) has confirmed plans to separate its consumer and pharmaceutical business units. However, an activist investor appears to want the big drugmaker to take more drastic ...

GlaxoSmithKline, looking to pump up in new favorite oncology, buys Tesaro for $5.1B By Angus Liu Dec 3, 2018 11:22am M&A mergers and acquisitions PARP inhibitors Emma Walmsley ...

As I looked into the story at the time, several things became clear: GlaxoSmithKline was promoting the drug for use by teenagers even though it had never been cleared by the FDA for anyone under ...